The Antimicrobial Peptide MAF-1A Acts on the Transcriptional Response of Candida parapsilosis
Abstract Background Candida parapsilosis is a major fungal pathogen that can cause sepsis in man. Novel antifungal agents are urgently required due to the threat of resistance to current therapeutic strategies. MAF-1A is a novel cationic antimicrobial peptide isolated from Musca domestica and is effective against a variety of Candida species. However, its antifungal mechanism is still unclear. Here, RNA-seq was used to identify differentially expressed genes (DEGs) in Candida parapsilosis after MAF-1A exposure. And then, we want to understand how the antimicrobial peptide MAF-1A work as an antifungal agent. Results The early (6 hour) response included 1122 genes with increased expression and 1065 genes with decreased expression. The late (18 hour) response was associated with the increased expression of 101 genes and decreased expression of 151 genes. When treated with MAF-1A from six to 18 hours, 42 genes were no longer expressed at elevated levels, and 25 genes that had a decreased expression pattern were reversed and demonstrated an increased expression pattern. KEGG enrichment showed that the DEGs caused by MAF-1A mainly involved amino acid synthesis and metabolism, oxidative phosphorylation, sterol synthesis and apoptosis. Conclusion These results indicate that MAF-1A may have multiple downstream effects in Candida parapsilosis. MAF-1A may exert antifungal activity by interfering with Candida parapsilosis cell membrane integrity and the function of certain organelles.